Sources

12 Total Sources

UniQure Wins FDA Path to Q3 Huntington's Filing Without New Trial

Left33%

Center50%

Right17%

Bloomberg58m ago

UniQure to File for Huntington's Gene Therapy Approval Without New Study After FDA Reversal

FDA lets UniQure seek accelerated approval for Huntington's therapy, shares skyrocket | Reuters

UniQure Stock Soars 75% After FDA Agrees to Gene Therapy Application Plan for Huntington's Disease

Seeking Alpha1h ago

uniQure Stock Surges as FDA Accepts AMT-130 Phase 1/2 Data for Accelerated Huntington's Approval

UniQure gets FDA nod for accelerated filing of Huntington's treatment, shares surge | WTVB | 1590 AM · 95.5 FM | The Voice of Branch County

Stocktwits8h ago

Why QURE Stock Is Soaring Today?

UniQure Stock (QURE) Rockets on an FDA Update - TipRanks.com

Ars Technica5h ago

FDA Overturns Rejection of UniQure's AMT-130 Gene Therapy for Huntington's Disease After Trump Official Ouster

UniQure will submit Huntington's therapy for approval, Eli Lilly buys 4E Therapeutics, and more biotech news

tickeron.com4h ago

Why Is uniQure N.V. (QURE) Stock Up +84% Today?

Yahoo Finance4h ago

uniQure N.V. (QURE) Stock Price, News, Quote & History - Yahoo Finance

poshuk.info4h ago

AMT-130 Gene Therapy for Huntington's Disease – Results, Mechanism of Action, and FDA Status